 |
 |
 |
 |
|
 |
Showing Treatment 1 to 25 of 881 Next 25 |
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma(The “ACT IV” Study) |
 |
San Francisco, CA USA |
 |
10/08/2012 |
 |
 |
 |
 |
 |
Details |
 |
Protocol H9H-MC-JBAI - Phase 1b/2a Study Combining LY2157299 with Standard Temozolomide-based Radiochemotherapy in Patients with Newly Diagnosed Malignant Glioma
|
 |
San Francisco, CA USA |
 |
10/08/2012 |
 |
 |
 |
Details |
 |
A Phase I Dose Escalation Study of Hypofractionated Stereotactic Radiotherapy with Bevacizumab in the Treatment of Recurrent Malignant Glioma
|
 |
San Francisco, CA USA |
 |
10/08/2012 |
 |
 |
 |
 |
 |
Details |
 |
Protocol H9H-MC-JBAL- A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate plus Lomustine Therapy compared to Lomustine Monotherapy in Patients with Recurrent Glioblastoma
|
 |
San Francisco, CA USA |
 |
10/08/2012 |
 |
 |
 |
Details |
 |
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study Evaluating the Efficacy and Safety of Onartuzumab in Combination with Bevacizumab or Onartuzumab Monotherapy in Patients with Recurrent Glioblastoma |
 |
San Francisco, CA USA |
 |
10/08/2012 |
 |
 |
 |
 |
 |
Details |
 |
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma (ReACT) |
 |
Cincinnati, OH USA |
 |
09/26/2012 |
 |
 |
 |
Details |
 |
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV) |
 |
Cincinnati, OH USA |
 |
09/26/2012 |
 |
 |
 |
 |
 |
Details |
 |
A Randomized Phase I/II Study of ABT-888 in Combination with Temozolomide in Recurrent (Temozolomide Resistant) Glioblastoma |
 |
Cincinnati, OH USA |
 |
09/26/2012 |
 |
 |
 |
Details |
 |
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma |
 |
Cincinnati, OH USA |
 |
09/26/2012 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma |
 |
Cincinnati, OH USA |
 |
09/26/2012 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Cincinnati, OH USA |
 |
09/26/2012 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I First-in-Human Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 595 in Subjects With Recurrent Malignant Glioma Expressing Mutant Epidermal Growth Factor Receptor Variant III (EGFRvIII) |
 |
Cincinnati, OH USA |
 |
09/26/2012 |
 |
 |
 |
Details |
 |
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma |
 |
New Orleans, LA USA |
 |
09/22/2012 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma |
 |
Baltimore, MD USA |
 |
09/22/2012 |
 |
 |
 |
Details |
 |
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma |
 |
Richmond, VA USA |
 |
09/22/2012 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma |
 |
Seattle, WA USA |
 |
09/22/2012 |
 |
 |
 |
Details |
 |
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma |
 |
Atlanta, GA USA |
 |
09/22/2012 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma |
 |
Charlottesville, VA USA |
 |
09/22/2012 |
 |
 |
 |
Details |
 |
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma |
 |
Cleveland, OH USA |
 |
09/22/2012 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma |
 |
Jacksonville, FL USA |
 |
09/22/2012 |
 |
 |
 |
Details |
 |
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma |
 |
Phoenix, AZ USA |
 |
09/22/2012 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma |
 |
Wichita, KS USA |
 |
09/22/2012 |
 |
 |
 |
Details |
 |
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma |
 |
Des Moines, IA USA |
 |
09/22/2012 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma |
 |
Rapid City, SD USA |
 |
09/22/2012 |
 |
 |
 |
Details |
 |
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma |
 |
Denver, CO USA |
 |
09/22/2012 |
 |
 |
 |
 |
 |